相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Theodore W. Laetsch et al.
LANCET ONCOLOGY (2018)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma
David S. Ziegler et al.
BRITISH JOURNAL OF CANCER (2018)
Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors
Frederic Fina et al.
ONCOTARGET (2017)
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report
Astrid K. Gnekow et al.
EUROPEAN JOURNAL OF CANCER (2017)
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
Alvaro Lassaletta et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Death Within 1 Month of Diagnosis in Childhood Cancer: An Analysis of Risk Factors and Scope of the Problem
Adam L. Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System
Scott Ryall et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2017)
Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor
Erin N. Kiehna et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2017)
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer
Filippo Pietrantonio et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee et al.
NEURO-ONCOLOGY (2017)
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
Alexander Drilon et al.
CANCER DISCOVERY (2017)
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer
Filippo Pietrantonio et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
Alan Mackay et al.
CANCER CELL (2017)
Potential role of larotrectinib (LOXO-101), a selective pan-TRK inhibitor, in NTRK fusion-positive recurrent glioblastoma
Alison M. Schram et al.
CANCER RESEARCH (2017)
Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications
Xiaoyu Chen et al.
BIOINFORMATICS (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study
Rahul Krishnatry et al.
CANCER (2016)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2016)
Profound clinical and radiological response to BRAF inhibition in a 2-month-old diencephalic child with hypothalamic/chiasmatic glioma
Alvaro Lassaletta et al.
PEDIATRIC BLOOD & CANCER (2016)
Comparative assessment of methods for the fusion transcripts detection from RNA-Seq data
Shailesh Kumar et al.
SCIENTIFIC REPORTS (2016)
BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma
Matthew Mistry et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
Thale Kristin Olsen et al.
NEURO-ONCOLOGY (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
Martin J. Aryee et al.
BIOINFORMATICS (2014)
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
Gang Wu et al.
NATURE GENETICS (2014)
Children <1 Year Show an Inferior Outcome When Treated According to the Traditional LGG Treatment Strategy: A Report From the German Multicenter Trial HIT-LGG 1996 for Children With Low Grade Glioma (LGG)
Cora Mirow et al.
PEDIATRIC BLOOD & CANCER (2014)
Long-Term Outcome of 4,040 Children Diagnosed With Pediatric Low-Grade Gliomas: An Analysis of the Surveillance Epidemiology and End Results (SEER) Database
Pratiti Bandopadhayay et al.
PEDIATRIC BLOOD & CANCER (2014)
Effect of Time From Diagnosis to Start of Radiotherapy on Children with Diffuse Intrinsic Pontine Glioma
Atmaram S. Pai Panandiker et al.
PEDIATRIC BLOOD & CANCER (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms
Come Raczy et al.
BIOINFORMATICS (2013)
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
Yael P. Mosse et al.
LANCET ONCOLOGY (2013)
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
Aria Vaishnavi et al.
NATURE MEDICINE (2013)
Low-level processing of Illumina Infinium DNA Methylation BeadArrays
Timothy J. Triche et al.
NUCLEIC ACIDS RESEARCH (2013)
Long-term Follow-up of the Wait and See Approach to Localized Perinatal Adrenal Neuroblastoma
Denis Andrew Cozzi et al.
WORLD JOURNAL OF SURGERY (2013)
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
Joann L. Ater et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
RET, ROS1 and ALK fusions in lung cancer
Kengo Takeuchi et al.
NATURE MEDICINE (2012)
Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas
Craig Horbinski et al.
NEURO-ONCOLOGY (2012)
FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution
Huanying Ge et al.
BIOINFORMATICS (2011)
BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
Cynthia Hawkins et al.
CLINICAL CANCER RESEARCH (2011)
deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data
Andrew McPherson et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
Daehwan Kim et al.
GENOME BIOLOGY (2011)
Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas
David T. W. Jones et al.
CANCER RESEARCH (2008)
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Christopher J. Sarkisian et al.
NATURE CELL BIOLOGY (2007)
A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors
David Dankort et al.
GENES & DEVELOPMENT (2007)
A negative feedback signaling network underlies oncogene-induced senescence
Stephanie Courtois-Cox et al.
CANCER CELL (2006)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Supratentorial grade II astrocytoma: biological features and clinical course
PH Wessels et al.
LANCET NEUROLOGY (2003)
Childhood cancer registries in Ontario, Canada: Lessons learned from a comparison of two registries
ML Greenberg et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
分享论文
